Vishay’s recovery is real enough on revenue, but the market is still overpaying for margin normalization

Vishay Intertechnology gave bulls the evidence they needed that the bottom in revenue has passed, but not the evidence needed to underwrite a normal-cycle earnings rebound. What was priced in was a modest return to growth against a troughing industrial and automotive backdrop, with the street at $781.2 million of revenue and $0.02 of EPS. What actually surprised was that revenue missed by -2.4%, while EPS came in at -$0.07 versus a near-zero estimate base where the percent surprise is not meaningful. That distinction matters because the stock story was not about whether Vishay could move off the bottom, but whether a move off the bottom would finally re-lever the model. Q2 says demand is improving, but the operating model is still absorbing depreciation, SG&A normalization, tariffs, input costs, and expansion capex before shareholders see it.

The cleanest way to read the print is to separate the company’s own operating progression from the street-comparison basis. On the company’s reported basis, Joel Smejkal framed the quarter as a guide-consistent sequential recovery: “For the second quarter, revenue grew sequentially 7% to $762 million, in line with our guidance.” That wording matters because it rejects the idea that the revenue miss was an execution failure, but it does not solve the market problem: consensus had already moved above the company’s delivery point. David McConnell’s bridge shows why the quality of the sequential revenue improvement was mixed, with the quarter reflecting a “4% increase in volume” and a “3% positive foreign currency impact related mostly to the euro.” A PM should not ignore the volume turn, because passive components and discretes typically need volume first before pricing or utilization repair. But the FX contribution means the revenue line overstated the organic demand acceleration visible to customers and competitors.

That revenue nuance explains why the gross margin response was so muted. Vishay’s revenue trough has been followed by a move back into the low-$700 million to low-$800 million band, but gross margin has not broken out of the high-teens zone that began after the 2023 downturn. Q2 revenue of $762.2 million was above Q1’s trough and up +2.8% year over year, yet gross margin was only 19.5%. The market may be missing that the recovery is already showing up in sales before it shows up in profitability, which means the next leg of the debate is not demand direction, but incremental margin. If revenue can move higher and gross margin remains near 20%, the equity is not getting a classic semi-cycle snapback.

The financial trajectory is therefore more ambiguous than the headline sequential revenue growth suggests. Gross margin has moved from 32.0% at the start of the historical series to 19.5% in Q2, and the latest quarter did not materially repair that gap despite the revenue improvement. Management did call the quarter’s gross margin the high end of guidance, but the absolute level is the investment issue. McConnell said, “Gross profit was $149 million, resulting in a gross margin of 19.5% at the high end of our guidance.” The phrase earns attention because management is claiming operational delivery relative to its own plan, while the margin number itself shows the plan is still low-return. This is the crux of the variant perception: the company can be right that it executed the quarter and the market can still be wrong to capitalize the recovery as if margins are normalizing quickly.

The Q3 guide reinforces that point rather than resolves it. Revenue is expected to be $775 million, plus or minus $20 million, and gross margin is expected to be 19.7%, plus or minus 50 basis points. A guide with revenue above Q2 but gross margin still under 20% tells us the marginal dollar is not yet carrying the fixed-cost absorption investors want. Management attributed the Q3 revenue guide to a 2% volume increase and some seasonality in Europe, which is consistent with gradual demand repair rather than a step-function rebound. The gross margin guide also includes tariff impacts and higher input costs, making the cost side a live constraint even as volumes improve. That is not a bearish call on end-market demand; it is a bearish call on the speed at which demand converts to earnings.

The capacity story explains why the earnings recovery is lagging the revenue recovery. Smejkal said, “Over the past 2.5 years, we have invested approximately $775 million to add capacity for high-growth, higher profit products.” That sentence is strategically important because it commits Vishay to a multi-year mix-upgrade argument, but the Q2 cash and depreciation data show the near-term burden. Total CapEx was $65 million, including $53 million designated for capacity expansion projects, while depreciation expense was $53 million. The company is still spending heavily enough that the P&L and cash flow are absorbing the investment phase before the promised higher-profit products show through. Free cash flow was negative $73 million, and stockholder returns were limited to the $13.6 million quarterly dividend. That mix is not fatal with a global cash and short-term investment balance of $479 million, but it limits the equity story to future margin realization rather than current cash conversion.

The backlog offers the strongest counterargument to a negative reading, and it is the reason the thesis should not be “short the cycle” in a simplistic way. Backlog increased to $1.2 billion and is now at 4.6 months, which supports management’s claim that demand has stabilized beyond a single quarter of shipments. If that backlog converts at better utilization while expansion products ramp, Vishay can still grow into the cost base. But the backlog must be judged against the P&L that exists today. Q2 GAAP operating margin was 2.9%, and adjusted EBITDA margin was 8.3%. Those figures show that the backlog is not yet priced or mixed in a way that restores earnings power. The bullish variant would require evidence that backlog conversion lifts gross margin faster than management’s Q3 guide implies. The current data do not show that yet.

The call tone moved in the same direction as the demand data, which makes management’s confidence credible but not decisive. The Q2 transcript registered sentiment of 0.44 and guidance_tone of 0.40, both materially better than the prior trough period, while ai_optimism reached 0.62. Yet uncertainty was still 36.4, and qa_evasiveness was 26.0. In other words, management sounded more constructive, but not cleaner. The tone history supports the same interpretation as the numbers: the prepared script improved faster than the answers. That gap matters in a cyclical semi name because prepared remarks can frame the turn, while Q&A usually reveals whether customers are pulling, inventories are normal, or pricing is stabilizing. Here, the tone improved enough to validate a demand bottom, but not enough to validate a margin inflection.

That delivery pattern also helps distinguish what the market should pay for now from what it should wait to pay for later. Q2 prepared_sentiment was 0.57, while qa_sentiment was 0.28, a split that says management was more confident in the scripted narrative than in the interactive detail. The later tone history shows that call quality can swing sharply, with the Q1 FY2026 call-over-call delta showing sentiment +0.38 and uncertainty -7.7, but that is exactly why investors should demand confirmation in numbers rather than rely on tone alone. For this event, the relevant conclusion is not that management was promotional. It is that the call language and the financials lined up on direction but diverged on magnitude: demand is better, while margin remains constrained.

The competitive context makes Vishay look like a recovering volume share story rather than a high-quality margin story. In the Power_Discrete peer set, VSH’s latest reported revenue YoY of +17.3% compares favorably with several peers, but its gross margin of 21.0% trails DIOD at 31.8% and ROHCY at 26.7%. That gap matters because the sector is not uniformly trapped at Vishay’s margin level. If a PM wants power discrete exposure with cleaner profitability, the peer table shows alternatives generating higher gross margin. Vishay’s argument is instead that its capacity expansion and bill-of-materials capture can lift mix over time. Until that shows up, the company deserves credit for revenue acceleration but not for peer-level earnings quality.

The supply-chain read-through is narrower than usual because the data pack names no customers and no suppliers for Vishay. That absence is itself useful discipline: this print should not be extrapolated to a named automotive, industrial, distributor, or wafer supplier relationship from the available evidence. The only customer-facing magnitude management gave was its target of 80% of the bill of materials in power applications, which frames Vishay’s design ambition but does not identify a named beneficiary. For unnamed customers, the $1.2 billion backlog and 4.6 months of coverage imply better component availability and demand visibility than at the trough. For unnamed suppliers, the $65 million of quarterly CapEx and $53 million of capacity expansion spending indicate continued equipment and capacity-related demand from Vishay, but no supplier-specific revenue read-through can be defended from this data pack.

The earnings-quality issue becomes clearer when GAAP and adjusted figures are kept on their proper bases. In the company’s own accounts, GAAP EPS was $0.01, but the street-comparison print shows adjusted EPS at -$0.07 versus $0.02 expected. That is not a contradiction; it is a reporting-basis distinction. For the stock, the adjusted loss matters because investors were underwriting a return to positive earnings faster than the cost structure allowed. The SG&A line also complicates the headline GAAP improvement because Q2 SG&A expenses were $127 million, including an $11 million benefit from a one-time favorable resolution. Excluding that benefit, SG&A would have been in the range of guidance, and Q3 SG&A is expected to be $138 million, plus or minus $2 million. The cost base therefore steps back up just as the company asks investors to believe in gradual gross margin improvement.

This is why the right investment conclusion is not that Vishay missed and therefore the cycle is broken, but that the market is likely mispricing the path from revenue recovery to earnings recovery. The demand bottom is increasingly defensible: revenue rose sequentially, backlog expanded, and the guide calls for higher volume. The margin bridge is not yet defensible: gross margin was 19.5% in Q2 and the Q3 midpoint is only 19.7%. With 2025 CapEx planned between $300 million to $350 million and at least 70% allocated to expansion projects, management is still prioritizing future capacity over near-term free cash flow. That may be the right strategic choice, but it shifts the burden of proof to order conversion, utilization, and mix. A stock can work on that setup only if investors believe the margin lag is temporary and measurable; Q2 did not provide enough evidence to make that leap.

What to watch next is specific. For Q3 2025, the first confirmation point is whether revenue lands inside the $775 million, plus or minus $20 million range and whether the implied 2% volume increase materializes without relying on another large currency tailwind. The second is gross margin versus 19.7%, plus or minus 50 basis points; a print below that range would break the recovery thesis because volume would again be failing to absorb cost inflation. The third is cost discipline, with SG&A expected at $138 million, plus or minus $2 million, after the Q2 one-time benefit rolls off. Finally, backlog must hold near $1.2 billion and 4.6 months while free cash flow improves from negative $73 million. If those numbers move together, the capacity thesis starts to earn credibility; if revenue rises but gross margin stays around 19.5%, the market is still paying too early for a recovery Vishay has not yet monetized.